MedTech I.Q.

The Cutting Edge of Medical Technology Content, Community & Collaboration

U.S Veterinary Biological Development and Registration

Event Details

U.S Veterinary Biological Development and Registration

Time: March 28, 2014 from 10am to 11am
Location: Online Event
Street: 161 Mission Falls Lane, Suite 216, Fremont, CA 94539, USA
City/Town: Fremont
Website or Map: http://bit.ly/1ahG9Vd
Phone: 8004479407
Event Type: webinar, pharma, medical, clinical, health
Organized By: GlobalCompliancePanel
Latest Activity: Feb 28, 2014

Export to Outlook or iCal (.ics)

Event Description

Overview: The Development of veterinary biologics, involves a complex series of clinical studies and analytical programs to assure the quality and effectiveness of these products. Biologicals are commonly vaccines and include conventional viral based products, bacterins, toxins, rDNA products and antibody products. 

The basic development programs for theses vaccines are similar, but differences will be highlighted. It should be recognized that unlike human vaccines the Center for Veterinary Biologics registers hundreds of types of vaccines, but all are developed and registered using the Master Seed concept to assure vaccines made years from now, and those developed years ago are made according to the same standards and the consumers can expect the same quality. 

Why should you Attend:Veterinary Biologicals - largely vaccines but also antibody products and certain test kits are commonly used in both our Companion Animals (cats, dogs, horses) and Livestock (cattle, swine, poultry and fish) to prevent and occasionally treat disease. Some of the diseases prevented by these products are for zoonotic diseases such as Rabies and Leptospirosis which can have serious if not fatal outcomes in humans. 

Areas Covered in the Session:
  • Over of the regulatory framework for veterinary biological and how if differs from pharmaceutical products, and the United State Departments of Agricultures Center for Veterinary Biologics
  • Master Seed concept
  • Clinical program for Efficacy
  • Clinical program for Safety
  • Analytical/manufacturing requirements
  • Labeling
  • Import and export considerations
  • Q&A

Who Will Benefit:
  • Researchers
  • Veterinarians
  • Start up ventures including vaccine companies
  • Students considering careers in veterinary Biologicals
  • Livestock producers
Hans Draayer has over 30 years of experience in the biological industry working for major corporations including Pfizer, SmithKline Beecham and Beecham Laboratories. During this time he has held various senior Regulatory and R&D management roles and has developed and licensed vaccines for all major species with the USDA Center for Veterinary Biologics. 

Quick Contact:

GlobalCompliancePanel
USA Phone:800-447-9407
webinars@globalcompliancepanel.com
http://www.globalcompliancepanel.com
Event Link -http://bit.ly/1ahG9Vd

Comment Wall

Comment

RSVP for U.S Veterinary Biological Development and Registration to add comments!

Join MedTech I.Q.

Attending (1)

© 2024   Created by CC-Conrad Clyburn-MedForeSight.   Powered by

Badges  |  Report an Issue  |  Terms of Service